Filing Flows › Comparisons › ESMC vs NRXS
Escalon Medical vs Neuraxis: ESMC and NRXS compared
Escalon Medical is the larger company: $3.9M of revenue in its latest quarter (Q4 FY26) against $1.9M for Neuraxis (Q2 2026). Neuraxis is growing faster (+116% against +50% a year earlier). Escalon Medical is more profitable, with an operating margin of 14.7% against -110.2%.
Where the money goes: ESMC and NRXS
Escalon Medical (ESMC) · Q4 FY26
Escalon Medical, Q4 FY26: revenue $3.9M (+50% year over year), operating margin 14.7%, net earnings $1.8M, operating cash flow −$251K. The chart follows the revenue to costs, profit and cash.
Neuraxis (NRXS) · Q2 2026
Neuraxis, Q2 2026: revenue $1.9M (+116% year over year), operating margin -110.2%, net loss $2.1M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
| Escalon Medical (ESMC) | Neuraxis (NRXS) | |
|---|---|---|
| Latest quarter | Q4 FY26 | Q2 2026 |
| Revenue | $3.9M | $1.9M |
| Revenue growth, Y/Y | +50% | +116% |
| Operating margin | 14.7% | -110.2% |
| Net earnings | $1.8M | −$2.1M |
| Net margin | 46.1% | -108.1% |
| Operating cash flow | −$251K | −$1.0M |
Where the revenue comes from
Escalon Medical
- Product: $3.7M (95%)
- Service: $202K (5%)
Questions
Which is bigger, Escalon Medical or Neuraxis?
Escalon Medical is the larger company: $3.9M of revenue in its latest quarter (Q4 FY26) against $1.9M for Neuraxis (Q2 2026).
Is Escalon Medical or Neuraxis growing faster?
Neuraxis is growing faster (+116% against +50% a year earlier).
Which is more profitable, Escalon Medical or Neuraxis?
Escalon Medical is more profitable, with an operating margin of 14.7% against -110.2%.
More: Escalon Medical earnings · how Escalon Medical makes money · Neuraxis earnings · how Neuraxis makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Oct 13, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.